List of Excipients in API atazanavir and cobicistat
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing atazanavir and cobicistat
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
ER Squibb & Sons LLC | EVOTAZ | atazanavir and cobicistat | 0003-3641 | CELLULOSE, MICROCRYSTALLINE | 2032-10-06 |
ER Squibb & Sons LLC | EVOTAZ | atazanavir and cobicistat | 0003-3641 | CROSCARMELLOSE SODIUM | 2032-10-06 |
ER Squibb & Sons LLC | EVOTAZ | atazanavir and cobicistat | 0003-3641 | CROSPOVIDONE | 2032-10-06 |
ER Squibb & Sons LLC | EVOTAZ | atazanavir and cobicistat | 0003-3641 | HYDROXYPROPYL CELLULOSE | 2032-10-06 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for atazanavir and cobicistat
Excipient focus: CELLULOSE, MICROCRYSTALLINE
atazanavir and cobicistat drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
atazanavir and cobicistat drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
atazanavir and cobicistat drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
atazanavir and cobicistat drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
atazanavir and cobicistat drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
atazanavir and cobicistat drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
atazanavir and cobicistat drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
atazanavir and cobicistat drug variants containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | atazanavir and cobicistat | 0003-3641 |
>Company | >Ingredient | >NDC |
atazanavir and cobicistat drug variants not containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.